anticancer drug

VECTIBIX® (panitumumab) Injection

VECTIBIX® (panitumumab) Injection

Vectibix is an epidermal growth factor receptor (EGFR) antagonist indicated for the treatment of wild-type RAS (defined as wild-type in both KRAS and NRAS as determined by an FDA-approved test for this use) metastatic colorectal cancer (mCRC)

SUTENT® (sunitinib malate) capsules

SUTENT® (sunitinib malate) capsules

Sunitinib is a kinase inhibitor present in SUTENT capsules as the malate salt. Sunitinib is a small molecule that inhibits multiple receptor tyrosine kinases (RTKs), some of which are implicated in tumor growth, pathologic angiogenesis, and metastatic progression of cancer.

YONSA- abiraterone acetate tablet

YONSA- abiraterone acetate tablet

Abiraterone acetate, the active ingredient of YONSA tablet is the acetyl ester of abiraterone. YONSA is indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer.

CYCLOPHOSPHAMIDE injection

CYCLOPHOSPHAMIDE injection

Cyclophosphamide is an alkylating drug indicated treatment of malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma

Adblock Detected!

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by whitelisting our website.